Information for patients & caregivers

Our commitment to people living with rare melanocortin-4 receptor (MC4R) pathway diseases extends well beyond the development of potential medicines. We embrace a responsibility to listen to the community, to help bolster both individual and collective understanding of these diseases and help transform their lives through optimal and stigma-free care.

We are committed to improving the understanding of rare MC4R pathway diseases, and we have developed resources to help share knowledge, recognise symptoms, and aid in diagnosis.